These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28097372)

  • 1. The role of neuropeptides in adverse myocardial remodeling and heart failure.
    Widiapradja A; Chunduri P; Levick SP
    Cell Mol Life Sci; 2017 Jun; 74(11):2019-2038. PubMed ID: 28097372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure.
    Brown RD; Ambler SK; Mitchell MD; Long CS
    Annu Rev Pharmacol Toxicol; 2005; 45():657-87. PubMed ID: 15822192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy during cardiac remodeling.
    Nishida K; Otsu K
    J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of adipokines on the heart: focus on adiponectin.
    Park M; Sweeney G
    Heart Fail Rev; 2013 Sep; 18(5):631-44. PubMed ID: 22893246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
    Veeraveedu PT; Sanada S; Okuda K; Fu HY; Matsuzaki T; Araki R; Yamato M; Yasuda K; Sakata Y; Yoshimoto T; Minamino T
    Biochem Pharmacol; 2017 Aug; 138():73-80. PubMed ID: 28450225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
    Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
    Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neuropeptides in cardiomyopathies.
    Dvorakova MC; Kruzliak P; Rabkin SW
    Peptides; 2014 Nov; 61():1-6. PubMed ID: 25149360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional brown adipose tissue limits cardiomyocyte injury and adverse remodeling in catecholamine-induced cardiomyopathy.
    Thoonen R; Ernande L; Cheng J; Nagasaka Y; Yao V; Miranda-Bezerra A; Chen C; Chao W; Panagia M; Sosnovik DE; Puppala D; Armoundas AA; Hindle A; Bloch KD; Buys ES; Scherrer-Crosbie M
    J Mol Cell Cardiol; 2015 Jul; 84():202-11. PubMed ID: 25968336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effects of baicalein on heart failure via modulation of Ca(2+) handling proteins in vivo and in vitro.
    Zhao F; Fu L; Yang W; Dong Y; Yang J; Sun S; Hou Y
    Life Sci; 2016 Jan; 145():213-23. PubMed ID: 26706290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
    Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.
    Rengo G; Cannavo A; Liccardo D; Zincarelli C; de Lucia C; Pagano G; Komici K; Parisi V; Scala O; Agresta A; Rapacciuolo A; Perrone Filardi P; Ferrara N; Koch WJ; Trimarco B; Femminella GD; Leosco D
    Circ Heart Fail; 2013 Nov; 6(6):1259-67. PubMed ID: 24029661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
    Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
    Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
    J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure.
    Song YH; Cai H; Gu N; Qian CF; Cao SP; Zhao ZM
    J Pharm Pharmacol; 2011 Apr; 63(4):541-9. PubMed ID: 21401606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
    Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
    Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology.
    Hofmann F
    Basic Res Cardiol; 2018 Jun; 113(4):31. PubMed ID: 29934662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.